APA   Click to copy
Elshorbagy, A., Lyons, A. R. M., Vallejo-Vaz, A., (...), Bourbon, M., (...), … K.Ray. (2024). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study. The Lancet Diabetes and Endocrinology, 12(11), 811–823. https://doi.org/10.1016/S2213-8587(24)00221-3

Chicago/Turabian   Click to copy
Elshorbagy, Amany, Alexander R.M. Lyons, A. Vallejo-Vaz, (...), M. Bourbon, (...), Marcello Arca, Maurizio R Averna, and K.Ray. “Association of BMI, Lipid-Lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: a Worldwide Cross-Sectional Study.” The Lancet Diabetes and Endocrinology 12, no. 11 (2024): 811–823.

MLA   Click to copy
Elshorbagy, Amany, et al. “Association of BMI, Lipid-Lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: a Worldwide Cross-Sectional Study.” The Lancet Diabetes and Endocrinology, vol. 12, no. 11, 2024, pp. 811–23, doi:10.1016/S2213-8587(24)00221-3.

@article{amany2024a,
  title = {Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.},
  year = {2024},
  issue = {11},
  journal = {The Lancet Diabetes and Endocrinology},
  pages = {811-823},
  volume = {12},
  doi = {10.1016/S2213-8587(24)00221-3},
  author = {Elshorbagy, Amany and Lyons, Alexander R.M. and Vallejo-Vaz, A. and (...) and Bourbon, M. and (...) and Arca, Marcello and Averna, Maurizio R and K.Ray}
}